CrossrefInfokarte
Could Mixed CAR T‐Cell Products and Overlapping Patients Overestimate the Risk of HLH With Tisagenlecleucel?
American Journal of Hematology · 2026-12 · 101 (12) · 3052-3053
DOI: 10.1002/ajh.70493 ↗Abstract
Kein Abstract verfügbar.
EUVIMED